Clinical trial Recruiting at 1 site Observational Ages 16 to 100

A platform for collecting cancer tissue samples

Official title: PINCER (A Platform Study for solId orgaN CancERs); an Agile Regional Platform Study to Deliver High Quality Translational Research

Run by University of Liverpool · NCT05650125 · Data updated 2026-11-12

This study is trying to gather cancer tissue samples from patients having surgery or biopsies to help with research on solid organ cancers.

Quick facts

Study typeObservational
Ages16 Years to 100 Years
SexAll
Enrollment2000 (estimated)
SponsorUniversity of Liverpool
Academic / other
Locations1 site (Liverpool)
StatusRecruiting
StartedJanuary 1, 2022
Main results expectedJanuary 1, 2030
Study endsJanuary 1, 2030
Registry record updatedAugust 1, 2025
Trial IDNCT05650125 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults undergoing biopsy or surgical resection for any solid organ cancer.

Probably not a fit

Patients who refuse or are unable to consent, as well as pediatric patients, will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to create a comprehensive platform for the collection of biosamples from patients undergoing surgery or biopsy for solid organ cancers. It will facilitate the efficient gathering of both historical and fresh tissue samples, along with matched clinical and radiological data, to support various translational research projects. Researchers can propose specific sub-studies that will be reviewed and approved by the PINCER steering committee, ensuring alignment with the overarching protocol. The focus is on maximizing access to high-quality biosamples for cancer research without generating a biobank.

Why it matters

Potential benefit: If successful, this study could significantly enhance the availability of high-quality biosamples for cancer research, leading to better understanding and treatment options for patients.

How similar studies have gone: Other studies utilizing similar biosampling platforms have shown success in enhancing cancer research, indicating that this approach is promising.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Biopsy or surgical resection as standard of care

Exclusion Criteria:

* Refusal or inability to consent, paediatric patients

Where it's running

  • University of Liverpool
    Liverpool, United Kingdom
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.